loading

Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-05-25 2025-02-23 2024-11-24 2024-08-25
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
14.64%
31.11
36.44 35.15 32.56 24.70
Cost Of Revenue
3.81%
23.32
22.46 25.31 21.48 19.32
Gross Profit
44.28%
7.791
13.98 9.845 11.08 5.387
Operating Expenses
25.45%
10.86
8.655 18.87 13.04 16.97
Benefits Costs and Expenses
8.54%
40.77
37.56 49.93 39.09 40.96
Costs And Expenses
8.54%
40.77
37.56 49.93 39.09 40.96
Operating Income/Loss
157.57%
-3.067
5.327 -9.029 -1.959 -11.58
Income/Loss From Continuing Operations Before Tax
766.97%
-9.658
-1.114 -14.78 -6.528 -16.25
Income Tax Expense/Benefit
909.09%
0.333
0.033 -0.008 0.043 -0.025
Income/Loss From Continuing Operations After Tax
771.05%
-9.991
-1.147 -14.77 -6.571 -16.23
Net Income/Loss
771.05%
-9.991
-1.147 -14.77 -6.571 -16.23
Preferred Stock Dividends And Other Adjustments
2.44%
0.922
0.90 2.61 2.132 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,962%
37.40
0.7388 37.02 34.36 30.86
Diluted Average Shares
4,962%
37.40
0.7388 37.02 34.36 30.86
Basic Earnings Per Share
866.67%
-0.29
-0.03 -0.47 -0.25 -0.53
Diluted Earnings Per Share
866.67%
-0.29
-0.03 -0.47 -0.25 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
2.44%
0.922
0.90 2.61 2.132 -
$22.68
price up icon 0.00%
drug_manufacturers_specialty_generic RGC
$23.30
price up icon 0.00%
drug_manufacturers_specialty_generic RDY
$14.16
price down icon 1.29%
$130.01
price up icon 1.75%
$13.86
price up icon 0.90%
$537.49
price up icon 1.12%
Kapitalisierung:     |  Volumen (24h):